Washington spent a generation arguing that there was exactly one way to make prescription drugs cheaper: cap the prices by law. The cheapest drugs in six decades arrived without a single price control.
Prescription drug prices have fallen to their lowest levels in more than sixty years, posting their steepest annual decline since 1963 — down 3.1 percent over the past year, according to Townhall. That is seven straight months of declines, the longest uninterrupted stretch of falling drug prices in the 80-year history of the category.
The mechanism was not a mandate. President Trump’s drug pricing agreements and TrumpRx pushed discount generics and GLP-1 drugs into the market, and prices moved — the ordinary, unglamorous result of forcing more sellers into a market that had been comfortably closed.
“The headline today says exactly that,” Trump told reporters. “It says prescription drug prices record sharpest drop in more than 60 years.” He added: “And I told you that was going to happen.”
House Speaker Mike Johnson took the victory lap on X. “Prescription drug prices are now at their LOWEST LEVELS in more than 60 years — because of @POTUS and Republicans working to bring down costs for all Americans,” Johnson wrote. “This is what delivering real, positive results for the American people looks like.”
Scott Jennings put the point more bluntly, and aimed it at both parties’ long record of promising this exact outcome. “We learned for the first time in 60 years, prescription drug prices are falling,” Jennings said. “Every single politician, everybody here who’s ever worked for ‘em said they were gonna do it. Trump and the Republicans finally did it. There is a story to tell.”
The National Republican Congressional Committee is already building a midterm message around it. “Democrats spent years promising to lower drug prices and never got it done,” NRCC spokesman Mike Marinella said. “Republicans did it in less than two years.”
The uncomfortable part for the left is not the partisan scoreboard. It is the method. The entire progressive case on pharmaceuticals rests on the premise that drug pricing is a market failure so total that only government-set prices can fix it — that competition is a fantasy and negotiation is a euphemism. Seven consecutive months of declines, driven by generics and new entrants rather than by a fee schedule, is a direct falsification of that premise.
It is also a reminder of what price caps actually do when they are imposed on a market that could have been opened instead: they hold a number down on paper while the supply behind it quietly thins out. Nothing thinned out here. More product went in, and the price came down, which is what happens when a market is allowed to work.
Sixty years of speeches, and the fix turned out to be competition.
Source: townhall.com
